4//SEC Filing
Arno Therapeutics, Inc 4
Accession 0000914190-14-000017
CIK 0001195116operating
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:26 PM ET
Size
12.9 KB
Accession
0000914190-14-000017
Insider Transaction Report
Form 4
HAMILTON WILLIAM F PHD
Director
Transactions
- Award
Stock Option (right to buy)
2014-01-24+34,224→ 34,224 totalExercise: $2.90Exp: 2024-01-24→ Common Stock (34,224 underlying)
Holdings
- 68,448
Stock Option (right to buy)
Exercise: $2.40Exp: 2023-11-04→ Common Stock (68,448 underlying) - 20,833
2013 Series E Warrants (right to buy)
Exercise: $2.40From: 2013-10-29Exp: 2014-10-31→ Common Stock (20,833 underlying) - 22,079
Common Stock
- 3,750
Stock Option (right to buy)
Exercise: $8.00Exp: 2019-09-29→ Common Stock (3,750 underlying) - 1,250
Stock Option (right to buy)
Exercise: $8.00Exp: 2020-11-05→ Common Stock (1,250 underlying) - 20,833
2013 Series D Warrants (right to buy)
Exercise: $4.00From: 2013-10-29Exp: 2018-10-29→ Common Stock (20,833 underlying)
Footnotes (4)
- [F1]Currently exercisable.
- [F2]Vests in three equal annual installments commencing 11/5/11.
- [F3]Vests in equal 36-monthly installments commencing 12/4/13.
- [F4]Vests in equal 12-monthly installments commencing 2/24/14.
Documents
Issuer
Arno Therapeutics, Inc
CIK 0001195116
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001195116
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:26 PM ET
- Size
- 12.9 KB